Neyret Group showcasing high speed inhalation device assembly and labelling at DDL 2025 Edinburgh

Chaponost, France: – Neyret Group, the leading manufacturer of customized automatic assembly and test machinery for the medical and life sciences sectors, will present its advanced assembly and labelling capabilities for inhalation medical devices at the 2025 Drug Delivery to the Lungs (DDL) Conference in Edinburgh.

This will be Neyret’s third consecutive appearance at this flagship event for the inhalation community, where the company returns as both exhibitor and co-sponsor.

High-speed medical device assembly

The Neyret Group stand (Booth 160) at the Edinburgh International Conference Centre will highlight a wide range of capabilities for companies seeking high-speed assembly, labelling, and printing solutions for respiratory medical devices and components.

Neyret and Lagniel assembly and labelling platforms can handle a broad spectrum of inhalation and spray technologies, including:

• pMDI (pressurized metered-dose inhalers)
• DPI (dry-powder inhalers)
• Nasal sprays
• Uni-dose and bi-dose sprays
• Metered aerosol valves
• Dose counters
• A wide variety of related components

The stand will display finished devices assembled using Neyret technologies, while large-format video screens will demonstrate indexed-motion and continuous-motion assembly processes performing multiple precision steps.

Silver Sponsors

Neyret Group will again serve as a Silver Sponsor of DDL, alongside its Italian sister company CB Automation (part of the Mech-i-tronic Group), which will exhibit tailored solutions for medical and parenteral delivery devices and integrated data systems from a nearby booth.

Neyret will be represented in Edinburgh by CEO Bruno Neyret and Sales Director Pascal Vansse.

Mr. Vansse commented:

“Since 2023, we have found DDL Edinburgh to be an excellent forum for presenting our know-how to pharma companies seeking high-speed assembly, labelling and printing solutions, and for connecting with leading partners.”

About Neyret Group

French-based Neyret Group, with a worldwide presence, designs and manufactures customized automatic assembly and test machines for the medical and life sciences industries.

The company produces indexed motion and continuous motion assembly, test and print machines that are fully customized to customer’s ideal requirements.

Neyret Group employs more than 270 people at three production sites: in France with Société Guy Neyret producing indexed machines in Chaponost, near Lyon, and Lagniel, producing continuous motion machines in Douvres-la-Délivrande near Caen, Normandy; and in the United States, with Neyret, Inc. producing indexed machines at Sugar Grove, Illinois.

Further information at: https://www.neyretgroup.com/en

About DDL 2025

The annual Drug Delivery to the Lungs (DDL) Conference is one of the world’s leading international meetings for pulmonary and nasal drug delivery, bringing together scientists, academics, clinicians, regulatory specialists and industry professionals.

The 36th edition, DDL 2025, is a three-day event opening 10 December 2025, once again at the Edinburgh International Conference Centre at The Exchange, near the University of Edinburgh.

The conference will feature four themed scientific sessions, including the Pat Burnell Young Investigator Award, in which selected finalists present their research and are evaluated by the DDL Organizing Committee.

Organised by The Aerosol Society, more information is available at: https://ddl-conference.com/

Resources

Click on Neyret Group Medical Device Assembly Machines for further information.